Oral semaglutide is currently only approved for type 2 diabetes management
Search the weight-management and metabolic-research forums for CagriSema vs Tirzepatide and you will find them ranked against each other like two entries in the same race a Novo Nordisk challenger versus Eli Lillys established dual-incretin drug, usually reduced to a single number: which one drops more body weight
Summary of GLP-1 shopping behaviour shifts GLP1 users reduce annual supermarket spend by roughly one third Consumers on GLP1 buy less food overall due to reduced appetite Purchases trend lower in calories sugar carbs and saturated fat Shoppers shift from ultraprocessed foods toward fresher minimally processed options Small individual changes could scale and reshape industry reformulation priorities With offlabel use surging, its virtually impossible to know how many people are currently taking GLP1 drugs like Wegovy or Mounjaro, or how many will be prescribed them in the years ahead
A randomized controlled trial published in the European Journal of Nutrition found that daily consumption of oral glutathione at 1,000 mg increased blood glutathione levels by 30-35% in red blood cells, plasma, and lymphocytes after 6 months of supplementation
Mohammed I, Ahmed WS, Al-Barazenji T, Dauleh H, Love DR, Hussain K